Preterm birth refers to any birth before 37 weeks of pregnancy. Preterm birth and low birth weight are leading causes of neonatal mortality. Factors such as infections, medical conditions, lifestyle habits, and genetic predisposition can increase the risk of preterm birth. Prom testing is done to detect preterm birth risks by analyzing fetal fibronectin levels in cervicovaginal secretions. Some innovative diagnostic tests for prom testing include rapid immunoassays and polymerase chain reaction (PCR)-based molecular assays. These tests provide quick, convenient, and accurate results to assess preterm birth risks and enable timely medical interventions.
The global preterm birth and prom testing market is estimated to be valued at US$ 1.69 Bn in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Innovative diagnostic tests (as referred to in the heading) are a key driver of growth in the preterm birth and prom testing market. Rapid immunoassays and PCR-based molecular assays provide crucial advantages over conventional prom testing methods such as quicker results, higher accuracy, and simplified testing procedures. This enhances patient management and outcomes. Additionally, rising awareness about preterm birth risks and available preventive measures is prompting more women to undergo prom testing, thereby boosting market revenues. Governments and organizations are focused on educating women and care providers to facilitate early prom testing and preterm birth prevention.
Segment Analysis
The preterm birth and prom testing market is segmented into product, testing method, and end user. The testing method segment is dominating the market currently due to rising number of preterm births around the globe. Among the testing method segment, the maternal serum screening tests sub-segment holds the largest share as it estimates the risk of having a baby with Down syndrome, Edwards syndrome, Patau syndrome or open spines.
PEST Analysis
Political: Governments across countries are focusing on women health issues and are taking necessary steps to reduce preterm birth rates. Various initiatives are being taken to spread awareness about prem birth conditions and available testing options.
Economic: Rising healthcare expenditure and increasing cases of preterm births are driving the market growth. However, high testing costs may hamper the market growth in low income countries.
Social: Growing health awareness among people regarding preterm birth risks and available testing options during pregnancy is propelling the market growth. Also, decline in the social stigma around prenatal testing is supporting market expansion.
Technological: Advancements in fetal testing methods like non-invasive prenatal testing and digital microfluidics-based assays are providing accurate detection of genetic abnormalities. Introduction of portable and home-use testing kits is also fueling the market.
Key Takeaways
The Global Preterm Birth And Prom Testing Market Size is expected to witness high growth during the forecast period. North America region currently dominates the market due to growing preterm birth prevalence and rising technological adoption in the region. As per estimates, over 10% of babies born in North America are preterm.
Key players operating in the preterm birth and prom testing market are Huawei Technologies Co., Ltd.,ZTE Corporation,Nokia Corporation,ADTRAN, Inc.,Calix, Inc.,Cisco Systems, Inc.,Ericsson AB,FiberHome Technologies Group,Fujitsu Ltd.,NEC Corporation,Sumitomo Electric Industries, Ltd.,Dasan Zhone Solutions, Inc.,Iskratel d.o.o.,Mitsubishi Electric Corporation,Tellabs, Inc. Among them, Huawei technologies holds the major market share due to its strong product portfolio and global presence.
The non-invasive prenatal testing segment is growing at a fastest pace during the forecast period as it provides accurate fetal chromosomal analysis from a maternal blood sample which is safer than invasive testing methods like amniocentesis. This increasing adoption of non-invasive prenatal tests is supporting the overall market growth.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it